Angiography — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Angiography is an imaging procedure that visualises the interior of blood vessels and organs by injecting a radiopaque contrast dye through a thin, flexible catheter placed into a major artery or vein. Real-time X-ray fluoroscopy or digital subtraction angiography (DSA) captures the dye as it moves through the vascular system, revealing the size, shape, and patency of vessels in extraordinary detail. The technique can be applied to virtually any vascular bed: coronary arteries (coronary angiography), cerebral vessels (cerebral angiography), aorta and its branches (aortography), pulmonary vessels (pulmonary angiography), and peripheral limb vessels (peripheral angiography). Modern angiography suites combine imaging with real-time therapeutic capability, allowing the same session to include balloon angioplasty, stent placement, thrombolysis, or embolisation. Catheter access is typically via the radial artery at the wrist or the femoral artery at the groin, chosen based on clinical context and operator preference. The procedure has been the gold standard for vascular diagnosis since the 1950s and remains irreplaceable for many indications despite the growth of non-invasive CT and MR angiography. Angiography is an imaging procedure that visualises the interior of blood vessels and organs by injecting a radiopaque contrast dye through a thin, flexible catheter placed into a major artery or vein under fluoroscopic (real-time X-ray) guidance. It was first performed in the 1920s and remains the gold-standard imaging technique for coronary artery disease, peripheral vascular disease, cerebrovascular disease, and organ vasculature. Modern digital subtraction angiography (DSA) removes bone and tissue background to display vessels with high clarity, dramatically improving diagnostic precision over earlier film-based techniques. Angiography is performed by interventional cardiologists, interventional radiologists, and neurosurgeons depending on the anatomical target.

Angiography is indicated whenever a definitive map of the vascular anatomy is required for diagnosis or to guide treatment. Common cardiac indications include suspected or confirmed coronary artery disease with stable angina uncontrolled by medication, acute ST-elevation myocardial infarction (STEMI) requiring emergency revascularisation, abnormal stress test or CT calcium score, and pre-operative cardiac risk assessment before major non-cardiac surgery. Neurological indications include subarachnoid haemorrhage with suspected intracranial aneurysm, arteriovenous malformation planning, and stroke evaluation when MRA is inconclusive. Peripheral vascular disease with rest pain, tissue loss, or critical limb ischaemia requires angiography to plan bypass or endovascular intervention. Pulmonary angiography is used for massive pulmonary embolism when thrombolysis or catheter-directed treatment is contemplated. Patients with renal impairment may receive iso-osmolar contrast with appropriate hydration protocols to reduce nephrotoxicity risk.

The patient is positioned on a radiolucent table and connected to cardiac monitoring and pulse oximetry. After skin preparation and local anaesthetic infiltration, the operator introduces a needle into the target artery — commonly the radial artery at the wrist (radial access) or the femoral artery at the groin (femoral access). A guidewire is passed through the needle, the needle is removed, and an introducer sheath is inserted over the wire. A guiding catheter is then advanced under fluoroscopic guidance to the vessel origin of interest. Radiopaque iodinated contrast dye is injected while X-ray images are captured at 15–30 frames per second using digital subtraction angiography, which electronically removes background bone and soft tissue to reveal only the contrast-filled vessels. For coronary angiography, different catheters are used to selectively engage the left and right coronary ostia. Lesion severity is assessed visually and with physiological measurements such as fractional flow reserve (FFR). Once the diagnostic images are complete and any intervention has been performed, the catheter and sheath are withdrawn and haemostasis is secured with manual pressure, a closure device, or a wrist compression band. After confirmation of stable vital signs, the sheath is removed at the access site and haemostasis achieved by manual compression for 10–15 minutes or using a vascular closure device. The patient is transferred to a recovery bay for monitoring. Diagnostic angiography alone typically takes 30–60 minutes; combined therapeutic procedures (stenting, embolisation) may take 1–3 hours.

Angiography provides the most accurate and detailed anatomical map of the vascular system available, with spatial resolution superior to CT or MR angiography for small-calibre vessels. Its principal benefit is enabling precise, evidence-based treatment decisions: patients with coronary artery disease who would benefit from bypass surgery versus stenting can be correctly triaged, avoiding unnecessary operations. Same-session interventions — opening a blocked artery, placing a stent, dissolving a clot, or embolising an aneurysm — transform a purely diagnostic examination into a therapeutic one, often resolving the problem in a single visit. For STEMI patients, emergency coronary angiography with primary PCI reduces one-year mortality by approximately 30% compared with fibrinolytic therapy alone. The procedure avoids the radiation of repeated CT scans in younger patients and delivers a definitive answer where non-invasive tests are equivocal. For critical limb ischaemia, accurate mapping allows limb-saving revascularisation that would not be possible without angiographic guidance.

The overall complication rate for elective diagnostic angiography is below 1% at experienced centres. Contrast-induced acute kidney injury occurs in 1–5% of patients and is higher in those with pre-existing renal impairment, diabetes, or dehydration; mitigated by adequate hydration and iso-osmolar contrast. Contrast allergy ranges from mild urticaria (1–3%) to anaphylaxis (0.02%); pre-medication with steroids and antihistamines is given to at-risk patients. Access-site complications include haematoma (2–3%), pseudoaneurysm, and, rarely, arteriovenous fistula. Stroke risk for cerebral and coronary angiography is approximately 0.1–0.5% for elective cases and higher in emergency settings. Radial access has virtually eliminated the risk of retroperitoneal haematoma associated with femoral access. Radiation exposure is unavoidable but minimised by limiting fluoroscopy time and frame rate. Cholesterol embolisation is a rare but serious complication affecting renal, mesenteric, and peripheral vessels.

Following radial-access angiography, a wrist compression band is applied for 2–4 hours and patients are observed for 2 hours before discharge home the same day. Femoral access requires 2–6 hours of bed rest with pressure applied to the puncture site. Patients should drink 1–2 litres of water over the following 12 hours to help flush contrast dye through the kidneys. Strenuous activity and heavy lifting are avoided for 24–48 hours for radial access and 3–5 days for femoral access. Any expanding haematoma, acute limb pain or pallor, chest pain, or difficulty urinating should prompt immediate return to the hospital. Medication review includes ensuring NSAIDs and metformin are temporarily withheld and restarted only after renal function is confirmed stable. Results are typically available within 24 hours and are reviewed with the cardiologist, neurologist, or vascular surgeon to plan the next step.